- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01733849
A Study to Estimate the Occurrence of Rotavirus Gastroenteritis in Children < 5 Years of Age, in Bulgaria and Latvia
An Observational Study to Estimate the Disease Burden of Rotavirus Gastroenteritis in Infants/Children Less Than Five Years of Age in Primary Care Settings, in Bulgaria and Latvia
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
A Primary care setting will include independent general practitioners (GP) (specialised in paediatrics) or independent paediatricians.
Stool samples will be collected from all enrolled subjects at Visit 1 (Day 0) and tested immediately after collection. The stool sample will be stored for 24 hours only, in case the test cannot be performed immediately after collection.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
-
Burgas, Bulgarien, 8000
- GSK Investigational Site
-
Burgas, Bulgarien, 8018
- GSK Investigational Site
-
Dobrich, Bulgarien, 9300
- GSK Investigational Site
-
Pazardzik, Bulgarien, 4400
- GSK Investigational Site
-
Pleven, Bulgarien, 5800
- GSK Investigational Site
-
Plovdiv, Bulgarien, 4000
- GSK Investigational Site
-
Ruse, Bulgarien, 7000
- GSK Investigational Site
-
Sliven, Bulgarien, 8800
- GSK Investigational Site
-
Sofia, Bulgarien, 1606
- GSK Investigational Site
-
Sofia, Bulgarien, 1505
- GSK Investigational Site
-
Sofia, Bulgarien, 1517
- GSK Investigational Site
-
Sofia, Bulgarien, 1528
- GSK Investigational Site
-
Stara Zagora, Bulgarien, 6000
- GSK Investigational Site
-
Varna, Bulgarien, 9000
- GSK Investigational Site
-
Veliko Turnovo, Bulgarien, 5000
- GSK Investigational Site
-
-
-
-
-
Balvi, Lettland, LV-4501
- GSK Investigational Site
-
Bauska, Lettland, LV-3901
- GSK Investigational Site
-
Broceni, Lettland, LV-3851
- GSK Investigational Site
-
Carnikava, Lettland, LV-2163
- GSK Investigational Site
-
Daugavpils, Lettland, LV-5401
- GSK Investigational Site
-
Daugavpils, Lettland, LV-5410
- GSK Investigational Site
-
Druva, Lettland, LV-3862
- GSK Investigational Site
-
Erglu pagasts, Lettland, LV-4840
- GSK Investigational Site
-
Grobina, Lettland, LV-3430
- GSK Investigational Site
-
Ikskile, Lettland, LV-5052
- GSK Investigational Site
-
Jekabpils, Lettland, LV-5201
- GSK Investigational Site
-
Jelgava, Lettland, LV-3001
- GSK Investigational Site
-
Jelgava, Lettland, LV-3002
- GSK Investigational Site
-
Jelgava, Lettland, LV-3007
- GSK Investigational Site
-
Jelgava, Lettland, LV-3008
- GSK Investigational Site
-
Kuldiga, Lettland, LV-3300
- GSK Investigational Site
-
Liepaja, Lettland, LV-3401
- GSK Investigational Site
-
Limbazi, Lettland, LV-4001
- GSK Investigational Site
-
Livani, Lettland, LV-5316
- GSK Investigational Site
-
Madona, Lettland, LV-4801
- GSK Investigational Site
-
Ogre, Lettland, LV-5001
- GSK Investigational Site
-
Ozolnieki, Lettland, LV-3018
- GSK Investigational Site
-
Pinki, Lettland, LV-2107
- GSK Investigational Site
-
Rezekne, Lettland, LV-4601
- GSK Investigational Site
-
Rezekne, Lettland, LV-4604
- GSK Investigational Site
-
Riga, Lettland, LV-1001
- GSK Investigational Site
-
Riga, Lettland, LV-1002
- GSK Investigational Site
-
Riga, Lettland, LV-1010
- GSK Investigational Site
-
Riga, Lettland, LV-1011
- GSK Investigational Site
-
Riga, Lettland, LV-1012
- GSK Investigational Site
-
Riga, Lettland, LV-1024
- GSK Investigational Site
-
Riga, Lettland, LV-1050
- GSK Investigational Site
-
Riga, Lettland, LV-1063
- GSK Investigational Site
-
Riga, Lettland, LV-1082
- GSK Investigational Site
-
Ropazi, Lettland, LV-2135
- GSK Investigational Site
-
Sigulda, Lettland, LV-2150
- GSK Investigational Site
-
Tukums, Lettland, LV-3101
- GSK Investigational Site
-
Valmiera, Lettland, LV-4200
- GSK Investigational Site
-
Valmiera, Lettland, LV-4201
- GSK Investigational Site
-
Vangazi, Lettland, LV-2136
- GSK Investigational Site
-
Ventspils, Lettland, LV-3601
- GSK Investigational Site
-
Ventspils, Lettland, LV-3602
- GSK Investigational Site
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Infants/children with home visits by the GPGP/paediatrician for the treatment of AGE or brought to the GP/paediatrician for AGE treatment during the study period.
- A male or female infant/child less than five years of age at the time of the GP/paediatrician visit. A child becomes ineligible on the day of her/his fifth birthday.
- Written informed consent obtained from the parents/legally acceptable representative (LARs) of the subject.
- Subjects who the investigator believes that his/her, parents/LARs can and will comply with the requirements of the protocol.
Exclusion Criteria:
• Child in care.
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: Kohort
- Tidsperspektiv: Blivande
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
---|---|
Group Bulgaria
Subjects in this group include infants/children from Bulgaria, less than five years of age with home visits by the GP/paediatrician for the treatment of AGE or brought to the GP/paediatrician for the treatment of AGE.
|
Samples will be tested to determine the presence or absence of rotavirus.
Log books
|
Group Latvia
Subjects in this group include infants/children from Latvia, less than five years of age with home visits by the GP/paediatrician for the treatment of AGE or brought to the GP/paediatrician for the treatment of AGE.
|
Samples will be tested to determine the presence or absence of rotavirus.
Log books
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
---|---|
Number of RV GE cases among the acute gastroenteritis (AGE) cases reported at primary care settings in infants/children less than five years of age.
Tidsram: At the time of enrollment of each subject (Day 0).
|
At the time of enrollment of each subject (Day 0).
|
Sekundära resultatmått
Resultatmått |
Tidsram |
---|---|
Symptoms related to AGE and their measures, stratified by rotavirus status for all the AGE cases reported by infants/children less than five years of age at the primary care settings.
Tidsram: Day 0 - Day 14+5 (At the time of phone call follow-up contact).
|
Day 0 - Day 14+5 (At the time of phone call follow-up contact).
|
Number of RV GE cases reported at each month by infants/children less than five years of age reported at the primary care settings.
Tidsram: At the time of enrollment of each subject (Day 0).
|
At the time of enrollment of each subject (Day 0).
|
Number of hospitalisations for RV GE and AGE, reported at the primary care settings.
Tidsram: At the time of phone call follow-up contact (14 to 19 days after enrollment).
|
At the time of phone call follow-up contact (14 to 19 days after enrollment).
|
Samarbetspartners och utredare
Sponsor
Publikationer och användbara länkar
Allmänna publikationer
- Tafalla M, Gardovska D, Gopala K, Kozlovska L. Primary care-based surveillance to estimate the proportion of rotavirus gastroenteritis among Latvian children below 5 years of age with acute gastroenteritis. Hum Vaccin Immunother. 2019;15(6):1272-1278. doi: 10.1080/21645515.2018.1534515. Epub 2018 Oct 31.
- Tiholova M, Gopala K, Berberova M, Strokova-Stoilova M, Tafalla M. Rotavirus gastroenteritis in children less than five years of age in primary care settings in Bulgaria: an observational study. Germs. 2016 Sep 1;6(3):97-105. doi: 10.11599/germs.2016.1095. eCollection 2016 Sep.
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 116621
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Infektioner, Rotavirus
-
GlaxoSmithKlineAvslutad
-
Academisch Medisch Centrum - Universiteit van Amsterdam...University of Padova; Centers for Disease Control and Prevention; Aga Khan... och andra samarbetspartnersAvslutad
-
Merck Sharp & Dohme LLCAvslutad
-
Sichuan Center for Disease Control and PreventionChina National Biotec Group Company LimitedOkänd
-
GlaxoSmithKlineAvslutadRotavirus gastroenterit | Nosokomial Rotavirus Gastroenterit
-
Institut PasteurRekrytering
-
GlaxoSmithKlineAvslutadInfektioner, Rotavirus | Rotavirus gastroenterit
-
University of ChileBharat Biotech International LimitedRekrytering
-
PT Bio FarmaAvslutadRotavirus gastroenteritIndonesien
Kliniska prövningar på Stool sample
-
Hillel Yaffe Medical CenterOkänd